MediGene
Christopher Plehn is a Research Associate at Medigene AG since April 2022. Prior to this role, Christopher served as a Tutor and Studienassistent at Universität Salzburg from April 2020 to October 2021. Christopher holds a Master of Science in Medical Biology from Universität Salzburg, completed in 2022.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.